Nobel laureate launches hepatitis C vaccine programme in Hong Kong

Sir Michael Houghton, Nobel laureate, has initiated a hepatitis C vaccine development programme at Hong Kong Baptist University, leveraging local funding, access to Chinese viral strains, and partnerships with mainland drugmakers. This marks a shift in his base from North America to Asia, potentially accelerating vaccine research. The programme's success is uncertain, but it highlights Hong Kong's growing role in biomedical research.

AI disclosure: Model-written summary of the source, not a verified fact. Check the sources. How Mosaic works